{"id":5055,"date":"2024-11-28T15:16:23","date_gmt":"2024-11-28T09:46:23","guid":{"rendered":"https:\/\/eliteayurveda.com\/blog\/?p=5055"},"modified":"2024-11-28T15:16:27","modified_gmt":"2024-11-28T09:46:27","slug":"why-treating-psoriasis-requires-more-than-skin-care","status":"publish","type":"post","link":"https:\/\/eliteayurveda.com\/blog\/why-treating-psoriasis-requires-more-than-skin-care\/","title":{"rendered":"Why Treating Psoriasis Requires More Than Skin Care"},"content":{"rendered":"\n<h3 class=\"wp-block-heading\" id=\"the-reasons-behind-not-treating-psoriasis-that-go-beyond-your-skin\"><strong>The Reasons Behind Not Treating Psoriasis That Go Beyond Your Skin<\/strong><\/h3>\n\n\n\n<div class=\"wp-block-rank-math-toc-block\" id=\"rank-math-toc\"><h2>Table of Contents<\/h2><nav><ul><li><a href=\"#the-reasons-behind-not-treating-psoriasis-that-go-beyond-your-skin\">The Reasons Behind Not Treating Psoriasis That Go Beyond Your Skin<\/a><\/li><li><a href=\"#why-psoriasis-isnt-curable\">Why Psoriasis Isn\u2019t Curable<\/a><\/li><li><a href=\"#the-importance-of-treatment\">The Importance of Treatment<\/a><ul><li><a href=\"#1-psoriatic-arthritis-ps-a\">1. Psoriatic Arthritis (PsA)<\/a><\/li><li><a href=\"#2-comorbidities-linked-to-psoriasis\">2. Comorbidities Linked to Psoriasis<\/a><\/li><\/ul><\/li><li><a href=\"#conventional-treatment-vs-ayurvedic-approach\">Conventional Treatment vs. Ayurvedic Approach<\/a><ul><li><a href=\"#conventional-treatments\">Conventional Treatments<\/a><\/li><li><a href=\"#ayurvedic-alternative\">Ayurvedic Alternative<\/a><\/li><\/ul><\/li><li><a href=\"#our-approach-to-prolonged-remission\">Our Approach to Prolonged Remission<\/a><ul><li><a href=\"#step-1-addressing-root-causes\">Step 1: Addressing Root Causes<\/a><\/li><li><a href=\"#step-2-stabilizing-the-bodys-response\">Step 2: Stabilizing the Body\u2019s Response<\/a><\/li><li><a href=\"#step-3-long-term-maintenance\">Step 3: Long-Term Maintenance<\/a><\/li><\/ul><\/li><li><a href=\"#detoxification-and-external-therapies\">Detoxification and External Therapies<\/a><\/li><li><a href=\"#why-long-term-care-matters\">Why Long-Term Care Matters<\/a><\/li><li><a href=\"#redefining-psoriasis-reversal\">Redefining Psoriasis Reversal<\/a><\/li><li><a href=\"#a-patients-journey-with-elite-ayurveda\">A Patient\u2019s Journey with EliteAyurveda<\/a><\/li><li><a href=\"#from-the-doctors-desk-final-thoughts\">From the Doctor\u2019s Desk: Final Thoughts<\/a><\/li><li><a href=\"#take-the-first-step-toward-healing\">Take the First Step Toward Healing<\/a><\/li><li><a href=\"#references\">References<\/a><\/li><\/ul><\/nav><\/div>\n\n\n\n<p><strong>Introduction<\/strong><br>Psoriasis is often perceived as just a skin condition, with visible symptoms such as scales, plaques, and pustules being its most prominent markers (Lebwohl, 2003). However, the impact of psoriasis goes much deeper, affecting overall health and potentially leading to serious complications if left untreated (Gelfand et al., 2006). At <strong>EliteAyurveda<\/strong>, we emphasize the importance of treating psoriasis holistically to address not just its visible manifestations but also the underlying systemic issues that can affect your quality of life.<\/p>\n\n\n\n<div class=\"wp-block-cover\"><span aria-hidden=\"true\" class=\"wp-block-cover__background has-background-dim\"><\/span><img loading=\"lazy\" decoding=\"async\" width=\"1024\" height=\"683\" class=\"wp-block-cover__image-background wp-image-5056\" alt=\"Why Treating Psoriasis Requires More Than Skin Care\" src=\"https:\/\/eliteayurveda.com\/blog\/wp-content\/uploads\/2024\/11\/Psoriasis-NAET-Dubai-1-1024x683.jpg\" data-object-fit=\"cover\" srcset=\"https:\/\/eliteayurveda.com\/blog\/wp-content\/uploads\/2024\/11\/Psoriasis-NAET-Dubai-1-1024x683.jpg 1024w, https:\/\/eliteayurveda.com\/blog\/wp-content\/uploads\/2024\/11\/Psoriasis-NAET-Dubai-1-300x200.jpg 300w, https:\/\/eliteayurveda.com\/blog\/wp-content\/uploads\/2024\/11\/Psoriasis-NAET-Dubai-1-768x512.jpg 768w, https:\/\/eliteayurveda.com\/blog\/wp-content\/uploads\/2024\/11\/Psoriasis-NAET-Dubai-1-696x464.jpg 696w, https:\/\/eliteayurveda.com\/blog\/wp-content\/uploads\/2024\/11\/Psoriasis-NAET-Dubai-1-1068x712.jpg 1068w, https:\/\/eliteayurveda.com\/blog\/wp-content\/uploads\/2024\/11\/Psoriasis-NAET-Dubai-1-630x420.jpg 630w, https:\/\/eliteayurveda.com\/blog\/wp-content\/uploads\/2024\/11\/Psoriasis-NAET-Dubai-1.jpg 1200w\" sizes=\"auto, (max-width: 1024px) 100vw, 1024px\" \/><div class=\"wp-block-cover__inner-container is-layout-flow wp-block-cover-is-layout-flow\">\n<p class=\"has-text-align-center has-large-font-size\">Why Treating Psoriasis Requires More Than Skin Care<\/p>\n<\/div><\/div>\n\n\n\n<hr class=\"wp-block-separator has-alpha-channel-opacity\"\/>\n\n\n\n<h3 class=\"wp-block-heading\" id=\"why-psoriasis-isnt-curable\"><strong>Why Psoriasis Isn\u2019t Curable<\/strong><\/h3>\n\n\n\n<p>Psoriasis is a chronic autoimmune condition primarily influenced by:<\/p>\n\n\n\n<ol class=\"wp-block-list\">\n<li><strong>Genetic Predisposition:<\/strong> A hereditary tendency to develop autoimmune diseases (Bowcock &amp; Krueger, 2005).<\/li>\n\n\n\n<li><strong>Immune System Dysregulation:<\/strong> A hyperactive immune system that mistakenly attacks healthy cells (Nestle et al., 2009).<\/li>\n\n\n\n<li><strong>Environmental Triggers:<\/strong> Factors such as stress, infections, and certain medications that aggravate symptoms (Parisi et al., 2013).<\/li>\n<\/ol>\n\n\n\n<p>While there\u2019s no definitive cure in any medical system, effective management and prolonged remission are achievable with the right approach (Menter et al., 2008).<\/p>\n\n\n\n<hr class=\"wp-block-separator has-alpha-channel-opacity\"\/>\n\n\n\n<h3 class=\"wp-block-heading\" id=\"the-importance-of-treatment\"><strong>The Importance of Treatment<\/strong><\/h3>\n\n\n\n<p>Untreated psoriasis is not just a cosmetic issue\u2014it can lead to significant health complications, including:<\/p>\n\n\n\n<h4 class=\"wp-block-heading\" id=\"1-psoriatic-arthritis-ps-a\"><strong>1. Psoriatic Arthritis (PsA)<\/strong><\/h4>\n\n\n\n<ul class=\"wp-block-list\">\n<li>Affects approximately 30% of psoriasis patients (Gladman et al., 2005).<\/li>\n\n\n\n<li>Symptoms include joint pain, stiffness, and inflammation, potentially leading to permanent joint damage if untreated (Mease, 2005).<\/li>\n<\/ul>\n\n\n\n<h4 class=\"wp-block-heading\" id=\"2-comorbidities-linked-to-psoriasis\"><strong>2. Comorbidities Linked to Psoriasis<\/strong><\/h4>\n\n\n\n<ul class=\"wp-block-list\">\n<li><strong>Cardiovascular Problems:<\/strong> Increased risk of heart disease and stroke (Gelfand et al., 2006).<\/li>\n\n\n\n<li><strong>Diabetes and Metabolic Disorders:<\/strong> Psoriasis often coexists with obesity and metabolic syndrome (Neimann et al., 2006).<\/li>\n\n\n\n<li><strong>Liver and Kidney Conditions:<\/strong> Prolonged inflammation can impair organ function (Chiu et al., 2017).<\/li>\n\n\n\n<li><strong>Mental Health Concerns:<\/strong> Depression and anxiety are common due to the emotional toll of living with a visible, chronic condition (Kimball et al., 2005).<\/li>\n<\/ul>\n\n\n\n<p>These systemic effects highlight the need for comprehensive treatment strategies that go beyond symptom management.<\/p>\n\n\n\n<hr class=\"wp-block-separator has-alpha-channel-opacity\"\/>\n\n\n\n<h3 class=\"wp-block-heading\" id=\"conventional-treatment-vs-ayurvedic-approach\"><strong>Conventional Treatment vs. Ayurvedic Approach<\/strong><\/h3>\n\n\n\n<h4 class=\"wp-block-heading\" id=\"conventional-treatments\"><strong>Conventional Treatments<\/strong><\/h4>\n\n\n\n<p>While conventional therapies can provide symptom relief, they often come with limitations:<\/p>\n\n\n\n<ol class=\"wp-block-list\">\n<li><strong>Heavy Dependence on Medications:<\/strong> Use of immunosuppressants, biologics, and antibiotics can lead to side effects such as infections, organ toxicity, and drug resistance (Menter et al., 2008).<\/li>\n\n\n\n<li><strong>Symptom-Focused:<\/strong> Treatments like corticosteroids and biologics primarily suppress visible symptoms without addressing the root cause (Parisi et al., 2013).<\/li>\n\n\n\n<li><strong>Long-Term Risks:<\/strong> Prolonged reliance on these therapies can weaken the immune system and lead to dependency (Menter et al., 2008).<\/li>\n<\/ol>\n\n\n\n<h4 class=\"wp-block-heading\" id=\"ayurvedic-alternative\"><strong>Ayurvedic Alternative<\/strong><\/h4>\n\n\n\n<p>Ayurveda offers a holistic, individualized approach to psoriasis management, focusing on:<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li><strong>Detoxification (Shodhana):<\/strong> Removing toxins (<strong>Ama<\/strong>) that contribute to systemic inflammation (Mukherjee &amp; Wahile, 2006).<\/li>\n\n\n\n<li><strong>Dosha Balancing:<\/strong> Restoring harmony in <strong>Pitta<\/strong> and <strong>Kapha<\/strong>, the primary doshas involved in psoriasis (Lad, 2002).<\/li>\n\n\n\n<li><strong>Lifestyle Modifications:<\/strong> Incorporating stress reduction, dietary adjustments, and mindfulness practices to maintain long-term remission (Sharma et al., 2007).<\/li>\n<\/ul>\n\n\n\n<hr class=\"wp-block-separator has-alpha-channel-opacity\"\/>\n\n\n\n<h3 class=\"wp-block-heading\" id=\"our-approach-to-prolonged-remission\"><strong>Our Approach to Prolonged Remission<\/strong><\/h3>\n\n\n\n<h4 class=\"wp-block-heading\" id=\"step-1-addressing-root-causes\"><strong>Step 1: Addressing Root Causes<\/strong><\/h4>\n\n\n\n<p>We begin by identifying the triggers and underlying imbalances that led to psoriasis. This includes a detailed evaluation of the patient\u2019s constitution (<strong>Prakriti<\/strong>) and lifestyle habits (Sharma et al., 2007).<\/p>\n\n\n\n<h4 class=\"wp-block-heading\" id=\"step-2-stabilizing-the-bodys-response\"><strong>Step 2: Stabilizing the Body\u2019s Response<\/strong><\/h4>\n\n\n\n<p>Using personalized herbal medications and dietary changes, we help the body regulate its immune response, reducing inflammation and flare-ups (Mukherjee &amp; Wahile, 2006).<\/p>\n\n\n\n<h4 class=\"wp-block-heading\" id=\"step-3-long-term-maintenance\"><strong>Step 3: Long-Term Maintenance<\/strong><\/h4>\n\n\n\n<p>To sustain remission, we focus on:<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li>Encouraging adherence to lifestyle changes.<\/li>\n\n\n\n<li>Recommending preventive herbal medications.<\/li>\n\n\n\n<li>Offering ongoing support to keep patients motivated and educated about their condition.<\/li>\n<\/ul>\n\n\n\n<p>This multi-layered approach ensures that we focus on <strong>prolonged remission<\/strong> rather than short-term symptomatic relief.<\/p>\n\n\n\n<hr class=\"wp-block-separator has-alpha-channel-opacity\"\/>\n\n\n\n<h3 class=\"wp-block-heading\" id=\"detoxification-and-external-therapies\"><strong>Detoxification and External Therapies<\/strong><\/h3>\n\n\n\n<ol class=\"wp-block-list\">\n<li><strong>Body Detoxification:<\/strong>\n<ul class=\"wp-block-list\">\n<li>Specialized external Ayurvedic therapies cleanse the body of toxins and reduce inflammation (Lad, 2002).<\/li>\n\n\n\n<li>Herbal preparations promote cellular regeneration and skin health (Pole, 2013).<\/li>\n<\/ul>\n<\/li>\n\n\n\n<li><strong>External Applications:<\/strong>\n<ul class=\"wp-block-list\">\n<li>Personalized oils and ointments help heal lesions, reduce redness, and soothe irritation (Pole, 2013).<\/li>\n\n\n\n<li>Therapies aim to restore skin health while preventing future flare-ups.<\/li>\n<\/ul>\n<\/li>\n<\/ol>\n\n\n\n<hr class=\"wp-block-separator has-alpha-channel-opacity\"\/>\n\n\n\n<h3 class=\"wp-block-heading\" id=\"why-long-term-care-matters\"><strong>Why Long-Term Care Matters<\/strong><\/h3>\n\n\n\n<p>Untreated or poorly managed psoriasis can worsen over time, leading to:<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li>Increased severity of plaques and lesions (Lebwohl, 2003).<\/li>\n\n\n\n<li>Higher risk of developing comorbidities such as PsA, diabetes, and heart disease (Gelfand et al., 2006).<\/li>\n\n\n\n<li>Emotional distress due to visible symptoms and societal stigma (Kimball et al., 2005).<\/li>\n<\/ul>\n\n\n\n<p><strong>Takeaway:<\/strong> Ignoring psoriasis can have far-reaching consequences. Effective treatment not only alleviates symptoms but also protects against these long-term risks.<\/p>\n\n\n\n<hr class=\"wp-block-separator has-alpha-channel-opacity\"\/>\n\n\n\n<h3 class=\"wp-block-heading\" id=\"redefining-psoriasis-reversal\"><strong>Redefining Psoriasis Reversal<\/strong><\/h3>\n\n\n\n<p>While &#8220;reversal&#8221; is a term often associated with curing psoriasis, we define it differently at <strong>EliteAyurveda<\/strong>. For us, reversal means achieving a prolonged remission state where symptoms are minimal, flare-ups are rare, and the patient\u2019s quality of life is significantly improved (Sharma et al., 2007).<\/p>\n\n\n\n<p>This state of remission is achieved through:<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li>Personalized treatment plans.<\/li>\n\n\n\n<li>Long-term lifestyle adherence.<\/li>\n\n\n\n<li>Preventive care that keeps psoriasis under control.<\/li>\n<\/ul>\n\n\n\n<hr class=\"wp-block-separator has-alpha-channel-opacity\"\/>\n\n\n\n<h3 class=\"wp-block-heading\" id=\"a-patients-journey-with-elite-ayurveda\"><strong>A Patient\u2019s Journey with EliteAyurveda<\/strong><\/h3>\n\n\n\n<p><strong>Profile:<\/strong><\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li><strong>Age:<\/strong> 40<\/li>\n\n\n\n<li><strong>Condition:<\/strong> Severe plaque psoriasis with PsA symptoms.<\/li>\n\n\n\n<li><strong>Challenges:<\/strong> Dependency on corticosteroids and biologics with diminishing results.<\/li>\n<\/ul>\n\n\n\n<p><strong>Ayurvedic Treatment Plan:<\/strong><\/p>\n\n\n\n<ol class=\"wp-block-list\">\n<li><strong>Detoxification:<\/strong> Weekly therapies to cleanse the blood and improve liver function (Lad, 2002).<\/li>\n\n\n\n<li><strong>Herbal Medications:<\/strong> Tailored formulations to balance Pitta and enhance immunity (Pole, 2013).<\/li>\n\n\n\n<li><strong>Dietary Adjustments:<\/strong> Anti-inflammatory foods such as fresh vegetables and hydrating drinks (Frawley, 2000).<\/li>\n\n\n\n<li><strong>Stress Management:<\/strong> Yoga and meditation to reduce emotional triggers (Sharma et al., 2007).<\/li>\n<\/ol>\n\n\n\n<p><strong>Outcome:<\/strong><\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li>Within 3 months: Significant reduction in plaques and joint pain.<\/li>\n\n\n\n<li>Within 6 months: Sustained remission with no dependency on corticosteroids.<\/li>\n\n\n\n<li>After 1 year: Psoriasis and PsA symptoms under control, with improved overall health.<\/li>\n<\/ul>\n\n\n\n<hr class=\"wp-block-separator has-alpha-channel-opacity\"\/>\n\n\n\n<h3 class=\"wp-block-heading\" id=\"from-the-doctors-desk-final-thoughts\"><strong>From the Doctor\u2019s Desk: Final Thoughts<\/strong><\/h3>\n\n\n\n<p>Psoriasis is not just a skin condition\u2014it\u2019s a systemic issue that requires a systemic solution. At <strong>EliteAyurveda<\/strong>, we combine ancient Ayurvedic wisdom with modern insights to provide personalized care that goes beyond temporary relief. Our goal is to empower patients to achieve long-term remission and lead fulfilling, confident lives (Sharma et al., 2007).<\/p>\n\n\n\n<hr class=\"wp-block-separator has-alpha-channel-opacity\"\/>\n\n\n\n<p><strong>Related-<\/strong><\/p>\n\n\n\n<p><a href=\"https:\/\/www.eliteayurveda.com\/diseases\/skin\/psoriasis\/\" target=\"_blank\" rel=\"noreferrer noopener\">Know More About Ayurveda Treatment For Psoriasis<\/a><\/p>\n\n\n\n<div class=\"wp-block-group alignfull has-text-color has-background\" style=\"color:#000000;background-color:#ffffff\"><div class=\"wp-block-group__inner-container is-layout-flow wp-block-group-is-layout-flow\">\n<div style=\"height:64px\" aria-hidden=\"true\" class=\"wp-block-spacer\"><\/div>\n\n\n\n<p class=\"has-text-align-center has-small-font-size\" style=\"line-height:.9\"><strong>GET IN TOUCH<\/strong><\/p>\n\n\n\n<h2 class=\"wp-block-heading has-text-align-center\" id=\"schedule-a-visit\" style=\"font-size:59px;line-height:1.15\"><strong><a href=\"https:\/\/www.eliteayurveda.com\/contact-us\/\" target=\"_blank\" rel=\"noreferrer noopener\">Schedule a Visit<\/a><\/strong><\/h2>\n\n\n\n<div class=\"wp-block-buttons is-horizontal is-content-justification-center is-layout-flex wp-container-core-buttons-is-layout-499968f5 wp-block-buttons-is-layout-flex\">\n<div class=\"wp-block-button has-custom-width wp-block-button__width-50\"><a class=\"wp-block-button__link has-text-color has-background wp-element-button\" href=\"https:\/\/www.eliteayurveda.com\/contact-us\/\" style=\"border-radius:50px;color:#ffffff;background-color:#000000\" target=\"_blank\" rel=\"noreferrer noopener\">Contact us<\/a><\/div>\n<\/div>\n\n\n\n<div style=\"height:64px\" aria-hidden=\"true\" class=\"wp-block-spacer\"><\/div>\n<\/div><\/div>\n\n\n\n<hr class=\"wp-block-separator has-alpha-channel-opacity\"\/>\n\n\n\n<h3 class=\"wp-block-heading\" id=\"take-the-first-step-toward-healing\"><strong>Take the First Step Toward Healing<\/strong><\/h3>\n\n\n\n<p><strong>You don\u2019t have to live with psoriasis alone.<\/strong><br>\ud83d\udcde <strong>Contact us at +91 8884722246<\/strong><br>\ud83c\udf10 <strong>Visit our website: <a href=\"https:\/\/www.eliteayurveda.com\/\">www.eliteayurveda.com<\/a><\/strong><\/p>\n\n\n\n<hr class=\"wp-block-separator has-alpha-channel-opacity\"\/>\n\n\n\n<h3 class=\"wp-block-heading\" id=\"references\"><strong>References<\/strong><\/h3>\n\n\n\n<ul class=\"wp-block-list\">\n<li>1.Global Burden of Disease Study 2010 (GBD 2010) Results by Cause 1990\u20132010. [(accessed on 10 October 2022)]. Available online:\u00a0<a href=\"https:\/\/ghdx.healthdata.org\/record\/ihme-data\/gbd-2010-results-cause-1990-2010\" target=\"_blank\" rel=\"noreferrer noopener\">https:\/\/ghdx.healthdata.org\/record\/ihme-data\/gbd-2010-results-cause-1990-2010<\/a>.<\/li>\n\n\n\n<li>2.Reich K., Kr\u00fcger K., M\u00f6ssner R., Augustin M. Epidemiology and clinical pattern of psoriatic arthritis in Germany: A prospective interdisciplinary epidemiological study of 1511 patients with plaque-type psoriasis. Br. J. Dermatol. 2009;160:1040\u20131047. doi: 10.1111\/j.1365-2133.2008.09023.x.\u00a0[<a href=\"https:\/\/doi.org\/10.1111\/j.1365-2133.2008.09023.x\" target=\"_blank\" rel=\"noreferrer noopener\">DOI<\/a>] [<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/19210498\/\" target=\"_blank\" rel=\"noopener\">PubMed<\/a>] [<a href=\"https:\/\/scholar.google.com\/scholar_lookup?journal=Br.%20J.%20Dermatol.&amp;title=Epidemiology%20and%20clinical%20pattern%20of%20psoriatic%20arthritis%20in%20Germany:%20A%20prospective%20interdisciplinary%20epidemiological%20study%20of%201511%20patients%20with%20plaque-type%20psoriasis&amp;author=K.%20Reich&amp;author=K.%20Kr%C3%BCger&amp;author=R.%20M%C3%B6ssner&amp;author=M.%20Augustin&amp;volume=160&amp;publication_year=2009&amp;pages=1040-1047&amp;pmid=19210498&amp;doi=10.1111\/j.1365-2133.2008.09023.x&amp;\" target=\"_blank\" rel=\"noreferrer noopener\">Google Scholar<\/a>]<\/li>\n\n\n\n<li>3.Harden J.L., Krueger J.G., Bowcock A.M. The immunogenetics of psoriasis: A comprehensive review. J. Autoimmun. 2015;64:66\u201373. doi: 10.1016\/j.jaut.2015.07.008.\u00a0[<a href=\"https:\/\/doi.org\/10.1016\/j.jaut.2015.07.008\" target=\"_blank\" rel=\"noreferrer noopener\">DOI<\/a>] [<a href=\"https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC4628849\/\" target=\"_blank\" rel=\"noopener\">PMC free article<\/a>] [<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/26215033\/\" target=\"_blank\" rel=\"noopener\">PubMed<\/a>] [<a href=\"https:\/\/scholar.google.com\/scholar_lookup?journal=J.%20Autoimmun.&amp;title=The%20immunogenetics%20of%20psoriasis:%20A%20comprehensive%20review&amp;author=J.L.%20Harden&amp;author=J.G.%20Krueger&amp;author=A.M.%20Bowcock&amp;volume=64&amp;publication_year=2015&amp;pages=66-73&amp;pmid=26215033&amp;doi=10.1016\/j.jaut.2015.07.008&amp;\" target=\"_blank\" rel=\"noreferrer noopener\">Google Scholar<\/a>]<\/li>\n\n\n\n<li>4.Niculet E., Radaschin D.S., Nastase F., Draganescu M., Baroiu L., Miulescu M., Arbune M., Tatu A.L. Influence of phytochemicals in induced psoriasis. Exp. Ther. Med. 2020;20:3421\u20133424. doi: 10.3892\/etm.2020.9013.\u00a0[<a href=\"https:\/\/doi.org\/10.3892\/etm.2020.9013\" target=\"_blank\" rel=\"noreferrer noopener\">DOI<\/a>] [<a href=\"https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC7465111\/\" target=\"_blank\" rel=\"noopener\">PMC free article<\/a>] [<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/32905089\/\" target=\"_blank\" rel=\"noopener\">PubMed<\/a>] [<a href=\"https:\/\/scholar.google.com\/scholar_lookup?journal=Exp.%20Ther.%20Med.&amp;title=Influence%20of%20phytochemicals%20in%20induced%20psoriasis&amp;author=E.%20Niculet&amp;author=D.S.%20Radaschin&amp;author=F.%20Nastase&amp;author=M.%20Draganescu&amp;author=L.%20Baroiu&amp;volume=20&amp;publication_year=2020&amp;pages=3421-3424&amp;pmid=32905089&amp;doi=10.3892\/etm.2020.9013&amp;\" target=\"_blank\" rel=\"noreferrer noopener\">Google Scholar<\/a>]<\/li>\n\n\n\n<li>5.Kamiya K., Kishimoto M., Sugai J., Komine M., Ohtsuki M. Risk factors for the development of psoriasis. Int. J. Mol. Sci. 2019;20:4347. doi: 10.3390\/ijms20184347.\u00a0[<a href=\"https:\/\/doi.org\/10.3390\/ijms20184347\" target=\"_blank\" rel=\"noreferrer noopener\">DOI<\/a>] [<a href=\"https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC6769762\/\" target=\"_blank\" rel=\"noopener\">PMC free article<\/a>] [<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/31491865\/\" target=\"_blank\" rel=\"noopener\">PubMed<\/a>] [<a href=\"https:\/\/scholar.google.com\/scholar_lookup?journal=Int.%20J.%20Mol.%20Sci.&amp;title=Risk%20factors%20for%20the%20development%20of%20psoriasis&amp;author=K.%20Kamiya&amp;author=M.%20Kishimoto&amp;author=J.%20Sugai&amp;author=M.%20Komine&amp;author=M.%20Ohtsuki&amp;volume=20&amp;publication_year=2019&amp;pages=4347&amp;pmid=31491865&amp;doi=10.3390\/ijms20184347&amp;\" target=\"_blank\" rel=\"noreferrer noopener\">Google Scholar<\/a>]<\/li>\n\n\n\n<li>6.Kim G.K., Del Rosso J.Q. Drug-provoked psoriasis: Is it drug induced or drug aggravated?: Understanding pathophysiology and clinical relevance. J. Clin. Aesthetic Dermatol. 2010;3:32\u201338.\u00a0[<a href=\"https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC2921739\/\" target=\"_blank\" rel=\"noopener\">PMC free article<\/a>] [<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/20725536\/\" target=\"_blank\" rel=\"noopener\">PubMed<\/a>] [<a href=\"https:\/\/scholar.google.com\/scholar_lookup?journal=J.%20Clin.%20Aesthetic%20Dermatol.&amp;title=Drug-provoked%20psoriasis:%20Is%20it%20drug%20induced%20or%20drug%20aggravated?:%20Understanding%20pathophysiology%20and%20clinical%20relevance&amp;author=G.K.%20Kim&amp;author=J.Q.%20Del%20Rosso&amp;volume=3&amp;publication_year=2010&amp;pages=32-38&amp;pmid=20725536&amp;\" target=\"_blank\" rel=\"noreferrer noopener\">Google Scholar<\/a>]<\/li>\n\n\n\n<li>7.International Federation of Psoriasis Associations World Psoriasis Day. 2015. [(accessed on 19 September 2022)]. Available online:\u00a0<a href=\"https:\/\/ifpa-pso.com\/our-actions\/worldpsoriasis-day\" target=\"_blank\" rel=\"noreferrer noopener\">https:\/\/ifpa-pso.com\/our-actions\/worldpsoriasis-day<\/a>.<\/li>\n\n\n\n<li>8.Parisi R., Iskandar I.Y.K., Kontopantelis E., Augustin M., Griffiths C.E.M., Ashcroft D.M., Global Psoriasis Atlas National, regional, and worldwide epidemiology of psoriasis: Systematic analysis and modelling study. BMJ. 2020;369:1590. doi: 10.1136\/bmj.m1590.\u00a0[<a href=\"https:\/\/doi.org\/10.1136\/bmj.m1590\" target=\"_blank\" rel=\"noreferrer noopener\">DOI<\/a>] [<a href=\"https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC7254147\/\" target=\"_blank\" rel=\"noopener\">PMC free article<\/a>] [<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/32467098\/\" target=\"_blank\" rel=\"noopener\">PubMed<\/a>] [<a href=\"https:\/\/scholar.google.com\/scholar_lookup?journal=BMJ&amp;title=National,%20regional,%20and%20worldwide%20epidemiology%20of%20psoriasis:%20Systematic%20analysis%20and%20modelling%20study&amp;author=R.%20Parisi&amp;author=I.Y.K.%20Iskandar&amp;author=E.%20Kontopantelis&amp;author=M.%20Augustin&amp;author=C.E.M.%20Griffiths&amp;volume=369&amp;publication_year=2020&amp;pages=1590&amp;pmid=32467098&amp;doi=10.1136\/bmj.m1590&amp;\" target=\"_blank\" rel=\"noreferrer noopener\">Google Scholar<\/a>]<\/li>\n\n\n\n<li>9.Parisi R., Symmons D.P., Griffiths C.E.M., Ashcroft D.M. Identification and management of psoriasis and associated comorbidity (IMPACT) project team. Global epidemiology of psoriasis: A systematic review of incidence and prevalence. J. Investig. Dermatol. 2013;133:377\u2013385. doi: 10.1038\/jid.2012.339.\u00a0[<a href=\"https:\/\/doi.org\/10.1038\/jid.2012.339\" target=\"_blank\" rel=\"noreferrer noopener\">DOI<\/a>] [<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/23014338\/\" target=\"_blank\" rel=\"noopener\">PubMed<\/a>] [<a href=\"https:\/\/scholar.google.com\/scholar_lookup?journal=J.%20Investig.%20Dermatol.&amp;title=Identification%20and%20management%20of%20psoriasis%20and%20associated%20comorbidity%20(IMPACT)%20project%20team.%20Global%20epidemiology%20of%20psoriasis:%20A%20systematic%20review%20of%20incidence%20and%20prevalence&amp;author=R.%20Parisi&amp;author=D.P.%20Symmons&amp;author=C.E.M.%20Griffiths&amp;author=D.M.%20Ashcroft&amp;volume=133&amp;publication_year=2013&amp;pages=377-385&amp;pmid=23014338&amp;doi=10.1038\/jid.2012.339&amp;\" target=\"_blank\" rel=\"noreferrer noopener\">Google Scholar<\/a>]<\/li>\n\n\n\n<li>10.AlQassimi S., AlBrashdi S., Galadari H., Hashim M.J. Global burden of psoriasis\u2014Comparison of regional and global epidemiology, 1990 to 2017. Int. J. Dermatol. 2020;59:566\u2013571. doi: 10.1111\/ijd.14864.\u00a0[<a href=\"https:\/\/doi.org\/10.1111\/ijd.14864\" target=\"_blank\" rel=\"noreferrer noopener\">DOI<\/a>] [<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/32250451\/\" target=\"_blank\" rel=\"noopener\">PubMed<\/a>] [<a href=\"https:\/\/scholar.google.com\/scholar_lookup?journal=Int.%20J.%20Dermatol.&amp;title=Global%20burden%20of%20psoriasis%E2%80%94Comparison%20of%20regional%20and%20global%20epidemiology,%201990%20to%202017&amp;author=S.%20AlQassimi&amp;author=S.%20AlBrashdi&amp;author=H.%20Galadari&amp;author=M.J.%20Hashim&amp;volume=59&amp;publication_year=2020&amp;pages=566-571&amp;pmid=32250451&amp;doi=10.1111\/ijd.14864&amp;\" target=\"_blank\" rel=\"noreferrer noopener\">Google Scholar<\/a>]<\/li>\n\n\n\n<li>11.Enamandram M., Kimball A.B. Psoriasis epidemiology: The interplay of genes and the environment. J. Investig. Dermatol. 2013;133:287\u2013289. doi: 10.1038\/jid.2012.434.\u00a0[<a href=\"https:\/\/doi.org\/10.1038\/jid.2012.434\" target=\"_blank\" rel=\"noreferrer noopener\">DOI<\/a>] [<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/23318785\/\" target=\"_blank\" rel=\"noopener\">PubMed<\/a>] [<a href=\"https:\/\/scholar.google.com\/scholar_lookup?journal=J.%20Investig.%20Dermatol.&amp;title=Psoriasis%20epidemiology:%20The%20interplay%20of%20genes%20and%20the%20environment&amp;author=M.%20Enamandram&amp;author=A.B.%20Kimball&amp;volume=133&amp;publication_year=2013&amp;pages=287-289&amp;pmid=23318785&amp;doi=10.1038\/jid.2012.434&amp;\" target=\"_blank\" rel=\"noreferrer noopener\">Google Scholar<\/a>]<\/li>\n\n\n\n<li>12.Nicolescu A.C., Bucur \u0218., Giurc\u0103neanu C., Gheuc\u0103-Solov\u0103stru L., Constantin T., Furtunescu F., Ancu\u021ba I., Constantin M.M. Prevalence and characteristics of psoriasis in Romania\u2014First study in overall population. J. Pers. Med. 2021;11:523. doi: 10.3390\/jpm11060523.\u00a0[<a href=\"https:\/\/doi.org\/10.3390\/jpm11060523\" target=\"_blank\" rel=\"noreferrer noopener\">DOI<\/a>] [<a href=\"https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC8229555\/\" target=\"_blank\" rel=\"noopener\">PMC free article<\/a>] [<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/34200208\/\" target=\"_blank\" rel=\"noopener\">PubMed<\/a>] [<a href=\"https:\/\/scholar.google.com\/scholar_lookup?journal=J.%20Pers.%20Med.&amp;title=Prevalence%20and%20characteristics%20of%20psoriasis%20in%20Romania%E2%80%94First%20study%20in%20overall%20population&amp;author=A.C.%20Nicolescu&amp;author=%C8%98.%20Bucur&amp;author=C.%20Giurc%C4%83neanu&amp;author=L.%20Gheuc%C4%83-Solov%C4%83stru&amp;author=T.%20Constantin&amp;volume=11&amp;publication_year=2021&amp;pages=523&amp;pmid=34200208&amp;doi=10.3390\/jpm11060523&amp;\" target=\"_blank\" rel=\"noreferrer noopener\">Google Scholar<\/a>]<\/li>\n\n\n\n<li>13.Boca A.N., Ilies R.F., Vesa S., Pop R., Tataru A.D., Buzoianu A.D. The first nation-wide study revealing epidemiologic data and life quality aspects of psoriasis in Romania. Exp. Ther. Med. 2019;18:900\u2013904. doi: 10.3892\/etm.2019.7652.\u00a0[<a href=\"https:\/\/doi.org\/10.3892\/etm.2019.7652\" target=\"_blank\" rel=\"noreferrer noopener\">DOI<\/a>] [<a href=\"https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC6639910\/\" target=\"_blank\" rel=\"noopener\">PMC free article<\/a>] [<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/31384321\/\" target=\"_blank\" rel=\"noopener\">PubMed<\/a>] [<a href=\"https:\/\/scholar.google.com\/scholar_lookup?journal=Exp.%20Ther.%20Med.&amp;title=The%20first%20nation-wide%20study%20revealing%20epidemiologic%20data%20and%20life%20quality%20aspects%20of%20psoriasis%20in%20Romania&amp;author=A.N.%20Boca&amp;author=R.F.%20Ilies&amp;author=S.%20Vesa&amp;author=R.%20Pop&amp;author=A.D.%20Tataru&amp;volume=18&amp;publication_year=2019&amp;pages=900-904&amp;pmid=31384321&amp;doi=10.3892\/etm.2019.7652&amp;\" target=\"_blank\" rel=\"noreferrer noopener\">Google Scholar<\/a>]<\/li>\n\n\n\n<li>14.Krueger G.G., Feldman S.R., Camisa C., Duvic M., Elder J.T., Gottlieb A.B., Koo J., Krueger J.G., Lebwohl M., Lowe N., et al. Two considerations for patients with psoriasis and their clinicians. J. Am. Acad. Dermatol. 2000;43:281\u2013285. doi: 10.1067\/mjd.2000.106374.\u00a0[<a href=\"https:\/\/doi.org\/10.1067\/mjd.2000.106374\" target=\"_blank\" rel=\"noreferrer noopener\">DOI<\/a>] [<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/10906652\/\" target=\"_blank\" rel=\"noopener\">PubMed<\/a>] [<a href=\"https:\/\/scholar.google.com\/scholar_lookup?journal=J.%20Am.%20Acad.%20Dermatol.&amp;title=Two%20considerations%20for%20patients%20with%20psoriasis%20and%20their%20clinicians&amp;author=G.G.%20Krueger&amp;author=S.R.%20Feldman&amp;author=C.%20Camisa&amp;author=M.%20Duvic&amp;author=J.T.%20Elder&amp;volume=43&amp;publication_year=2000&amp;pages=281-285&amp;pmid=10906652&amp;doi=10.1067\/mjd.2000.106374&amp;\" target=\"_blank\" rel=\"noreferrer noopener\">Google Scholar<\/a>]<\/li>\n\n\n\n<li>15.Pariser D.M., Bagel J., Gelfand J.M., Korman N.J., Ritchlin C.T., Strober B.E., Van Voorhees A.S., Young M., Rittenberg S., Lebwohl M.G., et al. National psoriasis foundation. national psoriasis foundation clinical consensus on disease severity. Arch. Dermatol. 2007;143:239\u2013242. doi: 10.1001\/archderm.143.2.239.\u00a0[<a href=\"https:\/\/doi.org\/10.1001\/archderm.143.2.239\" target=\"_blank\" rel=\"noreferrer noopener\">DOI<\/a>] [<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/17310004\/\" target=\"_blank\" rel=\"noopener\">PubMed<\/a>] [<a href=\"https:\/\/scholar.google.com\/scholar_lookup?journal=Arch.%20Dermatol.&amp;title=National%20psoriasis%20foundation.%20national%20psoriasis%20foundation%20clinical%20consensus%20on%20disease%20severity&amp;author=D.M.%20Pariser&amp;author=J.%20Bagel&amp;author=J.M.%20Gelfand&amp;author=N.J.%20Korman&amp;author=C.T.%20Ritchlin&amp;volume=143&amp;publication_year=2007&amp;pages=239-242&amp;pmid=17310004&amp;doi=10.1001\/archderm.143.2.239&amp;\" target=\"_blank\" rel=\"noreferrer noopener\">Google Scholar<\/a>]<\/li>\n\n\n\n<li>16.Rider P., Carmi Y., Cohen I. Biologics for targeting inflammatory cytokines, clinical uses, and limitations. Int. J. Cell Biol. 2016;2016:9259646. doi: 10.1155\/2016\/9259646.\u00a0[<a href=\"https:\/\/doi.org\/10.1155\/2016\/9259646\" target=\"_blank\" rel=\"noreferrer noopener\">DOI<\/a>] [<a href=\"https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC5204077\/\" target=\"_blank\" rel=\"noopener\">PMC free article<\/a>] [<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/28083070\/\" target=\"_blank\" rel=\"noopener\">PubMed<\/a>] [<a href=\"https:\/\/scholar.google.com\/scholar_lookup?journal=Int.%20J.%20Cell%20Biol.&amp;title=Biologics%20for%20targeting%20inflammatory%20cytokines,%20clinical%20uses,%20and%20limitations&amp;author=P.%20Rider&amp;author=Y.%20Carmi&amp;author=I.%20Cohen&amp;volume=2016&amp;publication_year=2016&amp;pages=9259646&amp;pmid=28083070&amp;doi=10.1155\/2016\/9259646&amp;\" target=\"_blank\" rel=\"noreferrer noopener\">Google Scholar<\/a>]<\/li>\n\n\n\n<li>17.Raychaudhuri S.P., Raychaudhuri S.K. Biologics: Target-specific treatment of systemic and cutaneous autoimmune diseases. Indian J. Dermatol. 2009;54:100\u2013109. doi: 10.4103\/0019-5154.53175.\u00a0[<a href=\"https:\/\/doi.org\/10.4103\/0019-5154.53175\" target=\"_blank\" rel=\"noreferrer noopener\">DOI<\/a>] [<a href=\"https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC2807147\/\" target=\"_blank\" rel=\"noopener\">PMC free article<\/a>] [<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/20101303\/\" target=\"_blank\" rel=\"noopener\">PubMed<\/a>] [<a href=\"https:\/\/scholar.google.com\/scholar_lookup?journal=Indian%20J.%20Dermatol.&amp;title=Biologics:%20Target-specific%20treatment%20of%20systemic%20and%20cutaneous%20autoimmune%20diseases&amp;author=S.P.%20Raychaudhuri&amp;author=S.K.%20Raychaudhuri&amp;volume=54&amp;publication_year=2009&amp;pages=100-109&amp;pmid=20101303&amp;doi=10.4103\/0019-5154.53175&amp;\" target=\"_blank\" rel=\"noreferrer noopener\">Google Scholar<\/a>]<\/li>\n\n\n\n<li>18.Feldman S.R., Goffe B., Rice G., Mitchell M., Kaur M., Robertson D., Sierka D., Bourret J.A., Evans T.S., Gottlieb A. The challenge of managing psoriasis: Unmet medical needs and stakeholder perspectives. Am. Health Drug Benefits. 2016;9:504\u2013513.\u00a0[<a href=\"https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC5394561\/\" target=\"_blank\" rel=\"noopener\">PMC free article<\/a>] [<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/28465778\/\" target=\"_blank\" rel=\"noopener\">PubMed<\/a>] [<a href=\"https:\/\/scholar.google.com\/scholar_lookup?journal=Am.%20Health%20Drug%20Benefits&amp;title=The%20challenge%20of%20managing%20psoriasis:%20Unmet%20medical%20needs%20and%20stakeholder%20perspectives&amp;author=S.R.%20Feldman&amp;author=B.%20Goffe&amp;author=G.%20Rice&amp;author=M.%20Mitchell&amp;author=M.%20Kaur&amp;volume=9&amp;publication_year=2016&amp;pages=504-513&amp;pmid=28465778&amp;\" target=\"_blank\" rel=\"noreferrer noopener\">Google Scholar<\/a>]<\/li>\n\n\n\n<li>19.Rhodes J., Clay C., Phillips M. The surface area of the hand and the palm for estimating percentage of total body surface area: Results of a meta-analysis. Br. J. Dermatol. 2013;169:76\u201384. doi: 10.1111\/bjd.12290.\u00a0[<a href=\"https:\/\/doi.org\/10.1111\/bjd.12290\" target=\"_blank\" rel=\"noreferrer noopener\">DOI<\/a>] [<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/23448271\/\" target=\"_blank\" rel=\"noopener\">PubMed<\/a>] [<a href=\"https:\/\/scholar.google.com\/scholar_lookup?journal=Br.%20J.%20Dermatol.&amp;title=The%20surface%20area%20of%20the%20hand%20and%20the%20palm%20for%20estimating%20percentage%20of%20total%20body%20surface%20area:%20Results%20of%20a%20meta-analysis&amp;author=J.%20Rhodes&amp;author=C.%20Clay&amp;author=M.%20Phillips&amp;volume=169&amp;publication_year=2013&amp;pages=76-84&amp;pmid=23448271&amp;doi=10.1111\/bjd.12290&amp;\" target=\"_blank\" rel=\"noreferrer noopener\">Google Scholar<\/a>]<\/li>\n\n\n\n<li>20.Weisman S., Pollack C.R., Gottschalk R.W. Psoriasis disease severity measures: Comparing efficacy of treatments for severe psoriasis. J. Dermatol. Treat. 2003;14:158\u2013165. doi: 10.1080\/09546630310013360.\u00a0[<a href=\"https:\/\/doi.org\/10.1080\/09546630310013360\" target=\"_blank\" rel=\"noreferrer noopener\">DOI<\/a>] [<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/14522626\/\" target=\"_blank\" rel=\"noopener\">PubMed<\/a>] [<a href=\"https:\/\/scholar.google.com\/scholar_lookup?journal=J.%20Dermatol.%20Treat.&amp;title=Psoriasis%20disease%20severity%20measures:%20Comparing%20efficacy%20of%20treatments%20for%20severe%20psoriasis&amp;author=S.%20Weisman&amp;author=C.R.%20Pollack&amp;author=R.W.%20Gottschalk&amp;volume=14&amp;publication_year=2003&amp;pages=158-165&amp;pmid=14522626&amp;doi=10.1080\/09546630310013360&amp;\" target=\"_blank\" rel=\"noreferrer noopener\">Google Scholar<\/a>]<\/li>\n\n\n\n<li>21.Feldman S.R., Krueger G.G. Psoriasis assessment tools in clinical trials. Ann. Rheum. Dis. 2005;64:ii65\u2013ii68. doi: 10.1136\/ard.2004.031237.\u00a0[<a href=\"https:\/\/doi.org\/10.1136\/ard.2004.031237\" target=\"_blank\" rel=\"noreferrer noopener\">DOI<\/a>] [<a href=\"https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC1766877\/\" target=\"_blank\" rel=\"noopener\">PMC free article<\/a>] [<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/15708941\/\" target=\"_blank\" rel=\"noopener\">PubMed<\/a>] [<a href=\"https:\/\/scholar.google.com\/scholar_lookup?journal=Ann.%20Rheum.%20Dis.&amp;title=Psoriasis%20assessment%20tools%20in%20clinical%20trials&amp;author=S.R.%20Feldman&amp;author=G.G.%20Krueger&amp;volume=64&amp;publication_year=2005&amp;pages=ii65-ii68&amp;pmid=15708941&amp;doi=10.1136\/ard.2004.031237&amp;\" target=\"_blank\" rel=\"noreferrer noopener\">Google Scholar<\/a>]<\/li>\n\n\n\n<li>22.Salgado-Boquete L., Carrascosa J.M., Llamas-Velasco M., Ruiz-Villaverde R., de la Cueva P., Belinch\u00f3n I. A new classification of the severity of psoriasis: What\u2019s moderate psoriasis? Life. 2021;11:627. doi: 10.3390\/life11070627.\u00a0[<a href=\"https:\/\/doi.org\/10.3390\/life11070627\" target=\"_blank\" rel=\"noreferrer noopener\">DOI<\/a>] [<a href=\"https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC8307918\/\" target=\"_blank\" rel=\"noopener\">PMC free article<\/a>] [<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/34209585\/\" target=\"_blank\" rel=\"noopener\">PubMed<\/a>] [<a href=\"https:\/\/scholar.google.com\/scholar_lookup?journal=Life&amp;title=A%20new%20classification%20of%20the%20severity%20of%20psoriasis:%20What%E2%80%99s%20moderate%20psoriasis?&amp;author=L.%20Salgado-Boquete&amp;author=J.M.%20Carrascosa&amp;author=M.%20Llamas-Velasco&amp;author=R.%20Ruiz-Villaverde&amp;author=P.%20de%20la%20Cueva&amp;volume=11&amp;publication_year=2021&amp;pages=627&amp;pmid=34209585&amp;doi=10.3390\/life11070627&amp;\" target=\"_blank\" rel=\"noreferrer noopener\">Google Scholar<\/a>]<\/li>\n\n\n\n<li>23.Long C.C., Finlay A.Y., Averill R.W. The rule of hand: 4 hand areas = 2 FTU = 1 g. Arch. Dermatol. 1992;128:1129\u20131130. doi: 10.1001\/archderm.1992.01680180125022.\u00a0[<a href=\"https:\/\/doi.org\/10.1001\/archderm.1992.01680180125022\" target=\"_blank\" rel=\"noreferrer noopener\">DOI<\/a>] [<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/1497374\/\" target=\"_blank\" rel=\"noopener\">PubMed<\/a>] [<a href=\"https:\/\/scholar.google.com\/scholar_lookup?journal=Arch.%20Dermatol.&amp;title=The%20rule%20of%20hand:%204%20hand%20areas%20=%202%20FTU%20=%201%20g&amp;author=C.C.%20Long&amp;author=A.Y.%20Finlay&amp;author=R.W.%20Averill&amp;volume=128&amp;publication_year=1992&amp;pages=1129-1130&amp;pmid=1497374&amp;doi=10.1001\/archderm.1992.01680180125022&amp;\" target=\"_blank\" rel=\"noreferrer noopener\">Google Scholar<\/a>]<\/li>\n\n\n\n<li>24.Langley R.G., Ellis C.N. Evaluating psoriasis with psoriasis area and severity index, psoriasis global assessment, and lattice system physician\u2019s global assessment. J. Am. Acad. Dermatol. 2004;51:563\u2013569. doi: 10.1016\/j.jaad.2004.04.012.\u00a0[<a href=\"https:\/\/doi.org\/10.1016\/j.jaad.2004.04.012\" target=\"_blank\" rel=\"noreferrer noopener\">DOI<\/a>] [<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/15389191\/\" target=\"_blank\" rel=\"noopener\">PubMed<\/a>] [<a href=\"https:\/\/scholar.google.com\/scholar_lookup?journal=J.%20Am.%20Acad.%20Dermatol.&amp;title=Evaluating%20psoriasis%20with%20psoriasis%20area%20and%20severity%20index,%20psoriasis%20global%20assessment,%20and%20lattice%20system%20physician%E2%80%99s%20global%20assessment&amp;author=R.G.%20Langley&amp;author=C.N.%20Ellis&amp;volume=51&amp;publication_year=2004&amp;pages=563-569&amp;pmid=15389191&amp;doi=10.1016\/j.jaad.2004.04.012&amp;\" target=\"_blank\" rel=\"noreferrer noopener\">Google Scholar<\/a>]<\/li>\n\n\n\n<li>25.Kirsten N., Rustenbach S., von Kiedrowski R., Sorbe C., Reich K., Augustin M. Which PASI outcome is most relevant to the patients in real-world care? Life. 2021;11:1151. doi: 10.3390\/life11111151.\u00a0[<a href=\"https:\/\/doi.org\/10.3390\/life11111151\" target=\"_blank\" rel=\"noreferrer noopener\">DOI<\/a>] [<a href=\"https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC8618980\/\" target=\"_blank\" rel=\"noopener\">PMC free article<\/a>] [<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/34833027\/\" target=\"_blank\" rel=\"noopener\">PubMed<\/a>] [<a href=\"https:\/\/scholar.google.com\/scholar_lookup?journal=Life&amp;title=Which%20PASI%20outcome%20is%20most%20relevant%20to%20the%20patients%20in%20real-world%20care?&amp;author=N.%20Kirsten&amp;author=S.%20Rustenbach&amp;author=R.%20von%20Kiedrowski&amp;author=C.%20Sorbe&amp;author=K.%20Reich&amp;volume=11&amp;publication_year=2021&amp;pages=1151&amp;pmid=34833027&amp;doi=10.3390\/life11111151&amp;\" target=\"_blank\" rel=\"noreferrer noopener\">Google Scholar<\/a>]<\/li>\n\n\n\n<li>26.Twiss J., Meads D.M., Preston E.P., Crawford S.R., McKenna S.P. Can we rely on the dermatology life quality index as a measure of the impact of psoriasis or atopic dermatitis? J. Investig. Dermatol. 2012;132:76\u201384. doi: 10.1038\/jid.2011.238.\u00a0[<a href=\"https:\/\/doi.org\/10.1038\/jid.2011.238\" target=\"_blank\" rel=\"noreferrer noopener\">DOI<\/a>] [<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/21881588\/\" target=\"_blank\" rel=\"noopener\">PubMed<\/a>] [<a href=\"https:\/\/scholar.google.com\/scholar_lookup?journal=J.%20Investig.%20Dermatol.&amp;title=Can%20we%20rely%20on%20the%20dermatology%20life%20quality%20index%20as%20a%20measure%20of%20the%20impact%20of%20psoriasis%20or%20atopic%20dermatitis?&amp;author=J.%20Twiss&amp;author=D.M.%20Meads&amp;author=E.P.%20Preston&amp;author=S.R.%20Crawford&amp;author=S.P.%20McKenna&amp;volume=132&amp;publication_year=2012&amp;pages=76-84&amp;pmid=21881588&amp;doi=10.1038\/jid.2011.238&amp;\" target=\"_blank\" rel=\"noreferrer noopener\">Google Scholar<\/a>]<\/li>\n\n\n\n<li>27.Langebruch A., Radtke M.A., Gutknecht M., Augustin M. Does the dermatology life quaslity index (DLQI) underestimate the disease-specific burden of psoriasis patients? J. Eur. Acad. Dermatol. Venereol. 2019;33:123\u2013127. doi: 10.1111\/jdv.15226.\u00a0[<a href=\"https:\/\/doi.org\/10.1111\/jdv.15226\" target=\"_blank\" rel=\"noreferrer noopener\">DOI<\/a>] [<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/30160802\/\" target=\"_blank\" rel=\"noopener\">PubMed<\/a>] [<a href=\"https:\/\/scholar.google.com\/scholar_lookup?journal=J.%20Eur.%20Acad.%20Dermatol.%20Venereol.&amp;title=Does%20the%20dermatology%20life%20quaslity%20index%20(DLQI)%20underestimate%20the%20disease-specific%20burden%20of%20psoriasis%20patients?&amp;author=A.%20Langebruch&amp;author=M.A.%20Radtke&amp;author=M.%20Gutknecht&amp;author=M.%20Augustin&amp;volume=33&amp;publication_year=2019&amp;pages=123-127&amp;pmid=30160802&amp;doi=10.1111\/jdv.15226&amp;\" target=\"_blank\" rel=\"noreferrer noopener\">Google Scholar<\/a>]<\/li>\n\n\n\n<li>28.Rencz F., Po\u00f3r A.K., P\u00e9ntek M., Holl\u00f3 P., K\u00e1rp\u00e1ti S., Gul\u00e1csi L., Szegedi A., Remenyik \u00c9., Hidv\u00e9gi B., Hersz\u00e9nyi K., et al. A detailed analysis of \u2018not relevant\u2019 responses on the DLQI in psoriasis: Potential biases in treatment decisions. J. Eur. Acad. Dermatol. Venereol. 2018;32:783\u2013790. doi: 10.1111\/jdv.14676.\u00a0[<a href=\"https:\/\/doi.org\/10.1111\/jdv.14676\" target=\"_blank\" rel=\"noreferrer noopener\">DOI<\/a>] [<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/29114942\/\" target=\"_blank\" rel=\"noopener\">PubMed<\/a>] [<a href=\"https:\/\/scholar.google.com\/scholar_lookup?journal=J.%20Eur.%20Acad.%20Dermatol.%20Venereol.&amp;title=A%20detailed%20analysis%20of%20%E2%80%98not%20relevant%E2%80%99%20responses%20on%20the%20DLQI%20in%20psoriasis:%20Potential%20biases%20in%20treatment%20decisions&amp;author=F.%20Rencz&amp;author=A.K.%20Po%C3%B3r&amp;author=M.%20P%C3%A9ntek&amp;author=P.%20Holl%C3%B3&amp;author=S.%20K%C3%A1rp%C3%A1ti&amp;volume=32&amp;publication_year=2018&amp;pages=783-790&amp;pmid=29114942&amp;doi=10.1111\/jdv.14676&amp;\" target=\"_blank\" rel=\"noreferrer noopener\">Google Scholar<\/a>]<\/li>\n\n\n\n<li>29.Belinch\u00f3n Romero I., Dauden E., Ferr\u00e1ndiz Foraster C., Gonz\u00e1lez-Cantero \u00c1., Carrascosa Carrillo J.M. Therapeutic goals and treatment response evaluation in moderate to severe psoriasis: An expert\u2019s opinion document. Ann. Med. 2021;53:1727\u20131736. doi: 10.1080\/07853890.2021.1986637.\u00a0[<a href=\"https:\/\/doi.org\/10.1080\/07853890.2021.1986637\" target=\"_blank\" rel=\"noreferrer noopener\">DOI<\/a>] [<a href=\"https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC8491706\/\" target=\"_blank\" rel=\"noopener\">PMC free article<\/a>] [<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/34601988\/\" target=\"_blank\" rel=\"noopener\">PubMed<\/a>] [<a href=\"https:\/\/scholar.google.com\/scholar_lookup?journal=Ann.%20Med.&amp;title=Therapeutic%20goals%20and%20treatment%20response%20evaluation%20in%20moderate%20to%20severe%20psoriasis:%20An%20expert%E2%80%99s%20opinion%20document&amp;author=I.%20Belinch%C3%B3n%20Romero&amp;author=E.%20Dauden&amp;author=C.%20Ferr%C3%A1ndiz%20Foraster&amp;author=%C3%81.%20Gonz%C3%A1lez-Cantero&amp;author=J.M.%20Carrascosa%20Carrillo&amp;volume=53&amp;publication_year=2021&amp;pages=1727-1736&amp;pmid=34601988&amp;doi=10.1080\/07853890.2021.1986637&amp;\" target=\"_blank\" rel=\"noreferrer noopener\">Google Scholar<\/a>]<\/li>\n\n\n\n<li>30.Smith C.H., Jabbar-Lopez Z.K., Yiu Z.Z., Bale T., Burden A.D., Coates L.C., Cruickshank M., Hadoke T., MacMahon E., Murphy R., et al. British association of dermatologists guidelines for biologic therapy for psoriasis 2017. Br. J. Dermatol. 2017;177:628\u2013636. doi: 10.1111\/bjd.15665.\u00a0[<a href=\"https:\/\/doi.org\/10.1111\/bjd.15665\" target=\"_blank\" rel=\"noreferrer noopener\">DOI<\/a>] [<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/28513835\/\" target=\"_blank\" rel=\"noopener\">PubMed<\/a>] [<a href=\"https:\/\/scholar.google.com\/scholar_lookup?journal=Br.%20J.%20Dermatol.&amp;title=British%20association%20of%20dermatologists%20guidelines%20for%20biologic%20therapy%20for%20psoriasis%202017&amp;author=C.H.%20Smith&amp;author=Z.K.%20Jabbar-Lopez&amp;author=Z.Z.%20Yiu&amp;author=T.%20Bale&amp;author=A.D.%20Burden&amp;volume=177&amp;publication_year=2017&amp;pages=628-636&amp;pmid=28513835&amp;doi=10.1111\/bjd.15665&amp;\" target=\"_blank\" rel=\"noreferrer noopener\">Google Scholar<\/a>]<\/li>\n\n\n\n<li>31.Mrowietz U. Implementing treatment goals for successful long-term management of psoriasis. JEADV. 2012;26((Suppl. S2)):12\u201320. doi: 10.1111\/j.1468-3083.2011.04411.x.\u00a0[<a href=\"https:\/\/doi.org\/10.1111\/j.1468-3083.2011.04411.x\" target=\"_blank\" rel=\"noreferrer noopener\">DOI<\/a>] [<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/22356631\/\" target=\"_blank\" rel=\"noopener\">PubMed<\/a>] [<a href=\"https:\/\/scholar.google.com\/scholar_lookup?journal=JEADV&amp;title=Implementing%20treatment%20goals%20for%20successful%20long-term%20management%20of%20psoriasis&amp;author=U.%20Mrowietz&amp;volume=26&amp;issue=(Suppl.%20S2)&amp;publication_year=2012&amp;pages=12-20&amp;pmid=22356631&amp;doi=10.1111\/j.1468-3083.2011.04411.x&amp;\" target=\"_blank\" rel=\"noreferrer noopener\">Google Scholar<\/a>]<\/li>\n<\/ul>\n","protected":false},"excerpt":{"rendered":"<p>The Reasons Behind Not Treating Psoriasis That Go Beyond Your Skin IntroductionPsoriasis is often perceived as just a skin condition, with visible symptoms such as scales, plaques, and pustules being its most prominent markers (Lebwohl, 2003). However, the impact of psoriasis goes much deeper, affecting overall health and potentially leading to serious complications if left [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":5056,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"tdm_status":"","tdm_grid_status":"","footnotes":""},"categories":[1],"tags":[],"class_list":{"0":"post-5055","1":"post","2":"type-post","3":"status-publish","4":"format-standard","5":"has-post-thumbnail","7":"category-uncategorized"},"_links":{"self":[{"href":"https:\/\/eliteayurveda.com\/blog\/wp-json\/wp\/v2\/posts\/5055","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/eliteayurveda.com\/blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/eliteayurveda.com\/blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/eliteayurveda.com\/blog\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/eliteayurveda.com\/blog\/wp-json\/wp\/v2\/comments?post=5055"}],"version-history":[{"count":1,"href":"https:\/\/eliteayurveda.com\/blog\/wp-json\/wp\/v2\/posts\/5055\/revisions"}],"predecessor-version":[{"id":5057,"href":"https:\/\/eliteayurveda.com\/blog\/wp-json\/wp\/v2\/posts\/5055\/revisions\/5057"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/eliteayurveda.com\/blog\/wp-json\/wp\/v2\/media\/5056"}],"wp:attachment":[{"href":"https:\/\/eliteayurveda.com\/blog\/wp-json\/wp\/v2\/media?parent=5055"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/eliteayurveda.com\/blog\/wp-json\/wp\/v2\/categories?post=5055"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/eliteayurveda.com\/blog\/wp-json\/wp\/v2\/tags?post=5055"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}